Nelson Azoulay

Nelson Azoulay has a diverse work experience in corporate development and business development roles. Nelson is currently the VP of Corporate Development at ImmunoGen, Inc since September 2022. Prior to that, they held the position of Executive Director of Corporate Development at the same company from November 2020 to September 2022.

Before joining ImmunoGen, Inc, Nelson worked at PDL BioPharma as the Senior Director of Business Development from January 2020 to October 2020. In this role, they were responsible for strategic planning, asset evaluation, and leading the sales process across various assets.

Prior to their time at PDL BioPharma, Nelson had significant experience at Syneos Health Consulting. Nelson held multiple roles including Director of Corporate Development and Commercial Strategy from September 2017 to August 2019, Senior Engagement Manager from January 2016 to September 2017, Engagement Manager from April 2015 to January 2016, Senior Consultant from September 2014 to April 2015, and Consultant from September 2013 to September 2014.

Nelson also worked at Omnicom, where they served as a Senior Analyst in Corporate Development and Commercial Strategy from July 2013 to September 2013, and as an Analyst from January 2012 to July 2013.

Overall, Nelson Azoulay has demonstrated expertise in corporate development, business development, strategic planning, and asset evaluation throughout their career.

Nelson Azoulay holds a Master of Business Administration (M.B.A.) degree with Dean's Honors from Columbia Business School. Nelson also has a Master's Degree in Neuroscience from McGill University, Faculty of Medicine. Additionally, they obtained a Bachelor's Degree with a focus on Pre-Med, Neuroscience, French & Spanish Literature from Wesleyan University.